Myomo Q4 2023 GAAP EPS $(0.070) Misses $(0.060) Estimate, Sales $4.756M Miss $4.787M Estimate
Portfolio Pulse from Benzinga Newsdesk
Myomo reported Q4 2023 GAAP EPS of $(0.070), missing the $(0.060) estimate, with sales of $4.756M also missing the $4.787M estimate. This represents a 17.66% increase in sales compared to the same period last year.
March 07, 2024 | 9:28 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Myomo missed Q4 2023 earnings and sales estimates, with a GAAP EPS of $(0.070) and sales of $4.756M, indicating a potential short-term negative impact on its stock price.
Missing both earnings and sales estimates typically leads to negative investor sentiment in the short term, potentially causing a decrease in stock price. However, the year-over-year sales growth might mitigate some negative impact.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100